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Abstract
Background: Neural conversion from human embryonic stem cells (hESCs) has been demonstrated in a variety of systems
including chemically defined suspension culture, not requiring extrinsic signals, as well as in an adherent culture method
that involves dual SMAD inhibition using Noggin and SB431542 (an inhibitor of activin/nodal signaling). Previous studies
have also determined a role for activin/nodal signaling in development of the neural plate and anterior fate specification.
We therefore sought to investigate the independent influence of SB431542 both on neural commitment of hESCs and
positional identity of derived neural progenitors in chemically defined substrate-free conditions.
Methodology/Principal Findings: We show that in non-adherent culture conditions, treatment with SB431542 alone for 8
days is sufficient for highly efficient and accelerated neural conversion from hESCs with negligible mesendodermal,
epidermal or trophectodermal contamination. In addition the resulting neural progenitor population has a predominantly
caudal identity compared to the more anterior positional fate of non-SB431542 treated cultures. Finally we demonstrate
that resulting neurons are electro-physiologically competent.
Conclusions: This study provides a platform for the efficient generation of caudal neural progenitors under defined
conditions for experimental study.
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Introduction
Controlled, scalable and directed differentiation of hESCs to the
neural lineage is necessary for the study of mechanisms underlying
human neural development as well as in modeling disease and
(potentially) for cell based therapy. Several recent reports have
demonstrated neural conversion of hESCs using chemically defined
conditions [1–8]. Efficient neurogenesis in chemically defined
medium (CDM) is based on the default model of neurogenesis
[9,10] where culture conditions are designed to minimise extrinsic
and intrinsic signals that divert differentiation to alternate fates.
Recent studies suggest that inhibition of both the activin/nodal and
BMP arms of the TGFb signaling pathways are necessary for highly
efficient neural conversion of adherent hESC cultures [2]. In view of
the established effect of TGFb signaling on neural development and
the differential effects of BMP antagonists on neural regional
identity, this raises the issue of whether TGFb/SMAD inhibition
based methods impose different positional identities on neural
progenitors to those observed in defined conditions without the use
of extrinsic signals. Against this background, and using a suspension
culture neuralisation protocol, we sought to examine the effect of
activin inhibition alone on the efficiency of neural conversion from
hESCs and positional identity of neural progeny when grown in
defined substrate free conditions [1].
Results
Activin/Nodal inhibition promotes accelerated and
highly efficient neural conversion of hESCs
Under control conditions, hESCs can be readily converted to
neural cells over 16 days (Fig. 1A) with concomitant loss of
pluripotency markers OCT4 and NANOG, and up regulation of
neural progenitor markers MUSASHI (D8) and SOX1 (D 16). By
comparison, addition of the activin/nodal receptor kinase (ALK4/
5/7) inhibitor SB431542 results in accelerated loss of OCT4 and
NANOG by D4, and gain of both MUSASHI (D4) and SOX1
(D8, Fig. 1B). Resulting cells are negative for mesendodermal
markers T and HNF3b, epidermal marker KRTAP (keratin
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7327
Figure 1. SB431542 accelerates neural induction from hESCs. Neural induction from hESCs using the HNM alone leads to loss of pluripotency
markers OCT4 and NANOG by day 8 and concomitant acquisition of neuroectodermal markers MUSASHI (day 8) and SOX1 (day 16) by
immunocytochemical analysis (A). Transcriptional analysis confirms loss of mesendodermal markers (T, HNF3b) by day 8 (A). SB431542 accelerates loss
of pluripotency markers OCT4 and NANOG to day 4, and up-regulation of neural marker MUSASHI to day 4 and SOX1 to day 8 (B). RT-PCR confirms
loss of mesendodermal markers (T, HNF3b) by day 8 and absence of epidermal marker (KRTAP) and trophectodermal markers (bHCG, CDX2) in both
control and SB431542 treated cells (B). Quantitative immunohistochemistry confirms significant acceleration in loss of pluripotency and expression of
neural markers when using SB431542 compared to control (C). * = p,0.05, ** P,0.01, Scale bars: all 100 mm.
doi:10.1371/journal.pone.0007327.g001
Generation of Caudal hESC-NSCs
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associated protein) and trophectodermal markers bHCG and
CDX2 (Fig. 1). Quantitative immunohistochemistry confirms
accelerated efficient neuralisation with 50.762.0% MUSASHI
positive cells at day 4 compared to 3.261.2% in control
conditions, and 40.667.0% SOX1 positive compared to negligible
SOX1 positive cells in the control group at day 8. Staining for
SOX 1 positivity at day 16 was 90.461.3% in the SB431542
treated cells and 46.467.4% under control conditions (Fig. 1C).
Activin/Nodal inhibition results in neural precursors with
a caudal identity
Despite robust MUSASHI and SOX1 expression, we found
that addition of SB431542 failed to induce high levels of PAX6
expression (6.761% PAX6 positive cells at day 8 compared to
31.263.4% in control conditions, Fig. 2C). To examine further
the influence of SB431542 on positional identity of neural
progenitors we undertook transcriptional profiling of rostro-caudal
markers. In addition to consistent down regulation of PAX6,
SB431542 treatment down-regulated all other anterior markers
tested including OTX1, OTX2 and EN2 when compared to
control conditions where these anterior markers are clearly
expressed (Fig. 2A&B). Immunohistochemistry of the anterior
marker OTX2 revealed significant down-regulation in SB431542
treated cells compared to control (3.361.4% vs. 33.763.6% in the
control group). In contrast, posterior markers GBX2, HOXB6 and
HOXC8 by transcriptional analysis are strongly expressed in the
Figure 2. Activin/nodal inhibition using the small compound SB431542 imposes a posterior positional identity on derived neural
progenitors. Under control conditions, transcriptional profiling reveals expression of a range of rostro-caudal markers, indicating an heterogeneous
positional identity of neural precursors (A). Immunohistochemistry confirms the presence of anterior markers PAX6 and OTX2 (A). Treatment with SB431542
causes a significant downregulation of anterior positional markers including PAX6, OTX1, OTX2 and themidbrain marker EN2 by transcriptional analysis and
significantly reduced expression of PAX6 and OTX2 by immunohistochemistry compared to control conditions (B&C). Posterior markers including GBX2,
HOXB6 and HOXC8 in the SB431542 treated group are strongly expressed at the RNA level (B) and quantitative immunohistochemistry of posterior marker
HOXB4 (C) reveals significant upregulation with SB431542 treatment. Transcriptional profiling of dorso-ventral markers suggests that a predominantly
dorsal identity within the caudal neuraxis is demonstrated by SB431542 generated hESC-NPCs (D). Scale bars all 100 mm * =p,0.05, *** P,0.001.
doi:10.1371/journal.pone.0007327.g002
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SB431542 treated cells, suggesting a direct neural conversion of
hESCs to cells with caudal spinal cord regional identity (Fig. 2B).
This is reinforced by HOXB4 quantitative immunohistochemistry
showing significant up-regulation in SB431542 treated cells
22.863.5% vs. 10.762.4% in control conditions (Fig. 2C).
Transcriptional profiling of dorsal-ventral markers reveals a
predominantly dorsal identity within the caudal neuraxis following
SB431542 treatment, identified by PAX7 expression, very weak
expression of the intermediate domain markers IRX3 and PAX6,
and an absence of the ventral marker NKX2.2 (Fig. 2D).
Neurons generated using SB431542 are electro-
physiologically competent
Precursors plated at day 16 generated highly enriched neurons
expressing b-III-tubulin after 4 days and synapsin, a marker of
neuronal maturation, from 7 days (Fig. 3A). Electrophysiological
recordings were next made to characterize the functional
properties of caudal neurons generated using SB431542 from 28
days post plating for terminal differentiation. Current injection
(300 ms pulses of between +20–100 pA) into terminally differen-
tiated neurons elicited action potentials in the majority of cells
tested (Fig. 3B). The action potentials were blocked by TTX
indicating that they were mediated by voltage-dependent Na+
channels. Neurons generated using SB431542 also exhibited
currents mediated by ionotropic glutamate receptors as evidenced
by the fact that the selective agonists AMPA and NMDA evoked
responses in these cells (Fig. 3C). In addition to currents evoked by
exogenous application of agonists, we also observed that these
neurons displayed currents evoked by synaptic activation of
ionotropic glutamate receptors. ‘Bursts’ of synaptic responses
could be elicited in an external recording solution containing
picrotoxin to block inhibitory GABAA receptor activation – these
‘bursts’ were blocked by TTX (Fig. 3D). Finally, we were able to
record TTX-resistant miniature synaptic events from SB431542
generated neurons. These events were blocked by the selective
AMPA receptor antagonist, CNQX, confirming that these events
were mediated by synaptically located AMPA receptors (Fig. 3E).
To verify that the NMDA receptors expressed also pass Ca2+ we
performed Fluo-3 Ca2+ imaging. Addition of 100 mM NMDA
triggered significant intracellular Ca2+ influx (Fig. 3Fi&ii).
Discussion
Lineage restriction and cell fate specification are the conse-
quence of interplay of multiple developmental signals, which are
regulated in a spatio-temporal manner. Here we demonstrate that
activin/nodal inhibition using the compound SB431542 influences
both the timing of neural conversion of human hESCs as well as
positional identity of neural progenitors consistent with the role of
nodal signaling in antagonizing pluripotency and its requirement
for forebrain specification.
A pre-requisite for experimental and therapeutic studies of hESCs
derived neural progenitors is the ability to efficiently neuralise and
then predictably manipulate lineage restriction and regional identity.
Recognition that under defined and serum free conditions ES cells
will undergo neurogenesis, by minimising extrinsic and intrinsic
signals that divert differentiation to alternate fates, allows the
manipulation and study of mechanisms underlying both neural
induction and neural lineage specification [2,8,9,11]. Neural
induction in this system is based on the default model of neurogenesis
which results typically in precursors with an anterior identity [9,10].
The activin/nodal signaling pathway has been implicated in the
inhibition of default neurectodermal differentiation and in the
maintenance of pluripotency in hESCs [12]. This pathway
cooperates with the FGF signaling pathway to maintain hESC
pluripotency [13]. In-vivo studies also suggest that nodal acts as an
inhibitor of neuroectoderm specification in mice [14]. Further-
more, the role of Nodal inhibition in neural induction in both
mouse and human ESCs in-vitro has also been suggested [10,12].
Against this background, we first investigated the effect of activin/
nodal inhibition alone on the timing and efficiency of neural
conversion from hESCs. Our results demonstrate that SB431542
(an activin/nodal receptor kinase inhibitor) accelerates the process
of neural induction from hESCs, an observation consistent with its
known actions on inhibiting pluripotency [15]. Specifically, we
find that the time taken to reach the major milestones of neural
induction (down-regulation of pluripotency markers and upregula-
tion of neural markers) is 4 days compared to 8 days under control
conditions, suggesting a significant increase in efficiency of neural
conversion using SB431542 alone.
In addition to neural conversion, there is accumulating evidence
to implicate nodal signaling in forebrain specification. Specifically,
ablation studies have shown that the anterior visceral endoderm
(AVE) is necessary for normal forebrain development with nodal
signaling being critical in this process [16–18]. The finding in this
study that nodal inhibition imposes a posterior positional identity
on hESC-derived neural progenitors is thus consistent with the
known function of nodal in vertebrate neurodevelopment. The
downregulation of OTX2 in SB431542 treated cultures is also
consistent with studies implicating the wild-type function of this
gene in normal anterior fate specification [19]. Similarly, the
relative absence of PAX6 in SB431542 treated cultures is in
keeping with the established role of PAX6 as a key regulator of
forebrain development. Previous studies have used PAX6 as an
early pan-neural progenitor marker [1,20,21] to show neural
lineage commitment and to support the neurogenic hypothesis of
dual SMAD inhibition by combined SB431542 and Noggin
treatment [2]. Since SB431542, and hence SMAD2/3, inhibition
alone is clearly sufficient for efficient neural conversion of hESCs,
it is likely that PAX6 expression primarily indicates positional
identity in this context.
We next demonstrate that neurons derived following SB431542
treatment of hESCs are electro-physiologically competent. In
addition demonstration that NMDA triggered significant intracel-
lular Ca2+ influx suggests that SB431542 generated neurons may
be a good model with which to study the downstream
physiological effects of various paradigms of NMDA receptor
activation in human neurons, including synaptic plasticity, gene
expression changes, as well as excitotoxicity.
In summary, we demonstrate that activin/nodal inhibition using
the compound SB431542 accelerates highly efficient neural
conversion of human ESCs. Derived neural progenitors have a
caudal identity consistent with the known effects of activin/nodal
signaling on anterior fate specification. The effect of different
neural induction protocols on the positional identity of resulting
progeny within the neuraxis is of clear importance for the
generation of defined neuronal populations. Together this study
provides a platform for the efficient generation of caudal neural
progenitors under defined conditions for experimental study.
Materials and Methods
hESC culture and neural induction
The hESC lines H9 obtained from the WiCell Research
Institute (Madison, WI) and HuES9 (hES facility, Harvard
University, Cambridge, MA) were used for this study, between
passages 30 and 70. Human ESC culture and neural induction
were carried out using an adapted protocol from that previously
Generation of Caudal hESC-NSCs
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Figure 3. Plated aggregates give rise to bIII positive neurons (A, upper image) that mature to synapsin positivity (A, lower image)
within one week. SB431542 treated hESCs give rise to neurons that are electrophysiologically active. Current-clamp recording from an SB431542
generated neuron (28 days post-plating) showing that injection of positive current, from a resting membrane potential of –58 mV, gives rise to action
potentials which are blocked by the voltage-dependent Na+ channel blocker, TTX (300 nM) (B). Whole-cell voltage-clamp recording from an
SB431542 generated neuron at 28 days post-plating, held at –60 mV, showing responses to bath application of the selective agonists AMPA (50 mM)
and NMDA (100 mM) – both agonists evoke inward currents which are associated with increases in the noise level of the recording (C). In the presence
of picrotoxin (50 mM) and in nominally Mg2+-free external recording solution TTX-sensitive ‘bursts’ of excitatory synaptic inputs are present in
SB431542 generated neurons (28 days post-plating, D). Examples of CNQX-sensitive miniature EPSCs recorded from an SB431542 generated neuron
at 28 days post-plating held at –70 mV and recorded in the presence of TTX (300 nM) and picrotoxin (50 mM) in an external recording solution
containing 1 mM MgCl2 to block NMDA receptor-mediated currents (E). NMDA receptor activation SB431542 generated neurons (28 days post-
plating) causes intracellular Ca2+ influx. Example Fluo-3 fluorescence images (Fi) of SB431542 generated neurons before and after treatment with
NMDA (100 mM for 1 minute). For comparison, a fluorescence image is also shown of the same field of cells 1 minute after treatment with ionomycin,
which causes massive Ca2+ influx and dye saturation, as well as an image after treatment with ionomycin + MnCl2, which quenches the dye, giving a
fluorescence value approximately equivalent to 100 nM Ca2+ (Fii) [26]. The images are pseudocoloured: cold colours indicate low fluorescence, and
warm colours indicate high fluorescence.
doi:10.1371/journal.pone.0007327.g003
Generation of Caudal hESC-NSCs
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published [1]. Briefly, hESCs were propagated in defined medium
supplemented with 8 ng/ml of FGF2, 10 ng/ml of Activin [22]
and 10 ng/ml of insulin. To generate NPCs, hESCs were first
washed in phosphate buffered saline (PBS), enzymatically
dissociated from the underlying mouse embryonic fibroblast
feeder layer by gentle pipetting. Detached colonies were
subsequently centrifuged and washed in fresh medium. Colonies
were next chopped at 150 mm intervals using a McIlwain tissue
chopper (Mickle Engineering, Gomshall, U.K.) before being
plated at a low density in chemically defined medium (CDM
which consisted of 50% IMDM (Gibco) plus 50% F12 plus
glutamax (Gibco), supplemented with 1.75 mM human recombi-
nant insulin (Roche), 0.38 mM transferrin (Roche), 450 mM of
monothioglycerol (Sigma), 10 ml/ml lipids (Gibco) and 5 mg/ml
bovine serum albumin fraction V (Sigma)) in 10-cm culture dishes
on an orbital shaker to prevent sphere aggregation or adherence.
Human ESC-NSCs were maintained in CDM in the presence of
20 ng/ml of FGF2 from day 8. 10 mM SB431542 (Tocris
Bioscience, Bristol, UK) was added to the experimental group
from day 0–8.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from dissociated and washed cells
using the RNeasy Mini Kit (Qiagen, Valencia, CA) following the
manufacturer’s instructions. The samples were next treated with
RNAse-free DNase (Qiagen) and cDNA was synthesized from
2 mg of RNA using Moloney murine leukemia virus reverse
transcriptase (Invitrogen) and oligo-dT primers. Polymerase chain
reaction (PCR) was carried out using Taq polymerase (Invitrogen).
PCR products were separated on a 2% agarose gel and visualized
with SYBR-Green (Invitrogen). The expression of the housekeep-
ing gene HPRT was used to normalize PCR reactions. Forward
and reverse primer sequences, annealing temperatures and PCR
cycles are provided in the supplementary information (Table S1).
Immunocytochemistry
Cells plated down on poly-D-lysine/laminin coated glass
coverslips were fixed with 4% fresh paraformaldehyde for 20
minutes at room temperature and washed three times with PBS (or
1 hour for spheres with subsequent cryoprotection in 30% sucrose
prior to OCT embedding and cryostat sectioning). Samples were
next blocked for 1 hour at room temperature with 0.3% Triton/
PBS/5% goat serum and then incubated overnight with primary
antibody in 0.2% Triton/PBS/2% goat serum at 4uC. After three
washes in PBS, secondary antibody (goat anti-mouse, Alexa Fluor
488 or 555, 1:1000) in PBS/Hoechst (1:4000) was next applied for
1 hour at room temperature. Primary antibodies used included
Oct4 (1:100; Santa Cruz Biotechnology Inc.), Musashi1 (1:500;
Chemicon), Sox1 (1:200, Chemicon), b-III tubulin (1:500; Sigma-
Aldrich), SynapsinI (1:500; Calbiochem), Pax6 and HoxB4 (1:50;
Developmental Studies Hybridoma Bank [DSHB], Iowa City).
Electrophysiological recordings
Whole-cell current-clamp and voltage clamp recordings were
made from SB431542 generated neurons at room temperature
(2162uC) using an Axopatch-1C amplifier (Molecular Devices,
Union City, CA) using methods as described previously[23,24].
Briefly, coverslips containing SB431542 generated neurons were
transferred to a recording chamber perfused with an external
recording solution composed of (in mM): 152 NaCl, 2.8 KCl, 10
HEPES, 2 CaCl2, 10 glucose pH 7.3 (320–330 mOsm). Patch
pipettes were made from thick-walled borosilicate glass (Harvard
Apparatus, Kent, UK) and filled with a K-gluconate-based
internal solution containing (in mM): 155 K-gluconate, 2 MgCl2,
10 Na-HEPES, 10 Na-PiCreatine, 2 Mg2-ATP and 0.3 Na3-GTP,
pH 7.3 (300 mOsm). For current-clamp recordings to determine
the intrinsic firing of SB431542 generated neurons, the external
recording solution was supplemented with antagonists of gluta-
mate and GABA ligand-gated ion channels (CNQX 5 mM; D-AP5,
50 mM, picrotoxin, 50 mM; strychnine 20 mM). For the recording
of whole-cell AMPA- and NMDA-evoked currents and synapti-
cally-mediated glutamate receptor responses the external solution
was supplemented with picrotoxin (50 mM) and strychnine
(20 mM). In all experiments where NMDA receptor-mediated
responses were studied a saturating concentration of the co-
agonist, glycine (50 mM), was also added to the external recording
solution. Miniature excitatory postsynaptic currents (mEPSCs)
recorded in solutions supplemented with 300 nM tetrodotoxin
(TTX), picrotoxin (50 mM), strychnine (20 mM) and MgCl2
(1 mM). Events were recorded for 5–10 minutes at a holding
potential of –70 mV. Fluo-3 Ca2+ imaging was performed as
described [25]. Cells were loaded with 5 mM Fluo3-AM (Invitro-
gen) for 20 minutes at room temperature, followed by extensive
washing in fresh medium. Images before and after NMDA
application were taken on a Leica AF6000 LX imaging system. To
verify the dynamic range of the indicator, it was first saturated by
adding ionomycin (50 mM) to the cells, then quenched by the
addition of MnCl2 (10 mM) which gives a fluorescence value
approximately equivalent to 100 nM Ca2+ [26].
Quantification and Statistical Analysis
All experiments used a minimum number of 3 unless otherwise
stated. A p value of ,0.05 was considered statistically significant.
Values are expressed as the mean6SEM. The Mann-Whitney
rank-sum test was used for nonparametric analysis using
GraphPad Prism 4 (Graph-Pad Software, Inc., San Diego).
Supporting Information
Table S1 Primer sequences and RTPCR conditions
Found at: doi:10.1371/journal.pone.0007327.s001 (0.07 MB
DOC)
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